The Advisory Committee on Immunization Practices voted Wednesday to recommend lowering the age at which adults can get a ...

Mpox and Smallpox Threats: Vaccine Development and Biosecurity Policy ...

The FDA has approved a new freeze-dried formulation of Jynneos (smallpox and mpox vaccine, live, non-replicating).

The availability of suzetrigine may represent a critical step in addressing the nation’s pain management crisis. While questions remain about its cost, adoption, and long-term efficacy, its novel ...

Vaccination campaigns have nearly eradicated some of the most deadly and transmissible diseases. In a rising tide of vaccine ...

China on Thursday reported an outbreak of monkeypox virus, specifically the Ib sub-branch, with four associated cases. The ...

Peter H. Gilligan, Ph.D., D(ABMM) emeritus and F(AAM) was a medical microbiologist at UNC Health for 35 years. Here, he ...

Peter H Gilligan, Ph.D., D(ABMM) emeritus and F(AAM) was a medical microbiologist at UNC Health for 35 years. Here, he ...

FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1 ...

The vaccine remains available ... "we had responded to all of the FDA’s information requests and we believe that our BLA is ready for approval. As of today, we continue to wait on action from ...

FDA set an April 1 deadline for full approval but is delaying the decision, citing the need for more data. Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall ...